<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02326649</url>
  </required_header>
  <id_info>
    <org_study_id>140550</org_study_id>
    <nct_id>NCT02326649</nct_id>
  </id_info>
  <brief_title>Noninvasive Measurement of CO Using Impedance Cardiography in Patients With CHD</brief_title>
  <official_title>Noninvasive Measurement of Cardiac Output Using Impedance Cardiography in Patients With Congenital Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the capability of a non-invasive instrument (the PhysioFlow impedance
      cardiography instrument) to measure cardiac output in patients with congenital heart disease
      (CHD). This instrument works by placing electrodes on the skin of a patient and measuring
      electrical impedance through the chest, which is proportional to blood volume and blood flow
      at any given time. The instrument has been validated in patients with structurally normal
      hearts, but in the only two studies using it for patients with CHD, it was deemed too
      inaccurate for clinical use. The manufacturer of the device would require access to data on
      the patients in order to improve its accuracy, and that has not been feasible thus far. This
      study would begin by comparing cardiac output based on the PhysioFlow monitor to standard
      techniques, then after possible changes to the instrument to enhance accuracy, would test the
      instrument again in the same way.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The measurement of cardiac output (CO) is important for a wide variety of patients under
      multiple conditions. At present, gold standard techniques for measurement of CO include
      velocity encoded phase contrast MRI. Both of these techniques are valid in patients with
      structural CHD. Disadvantages of these techniques include the requirement of significant time
      and expertise, and the high cost and anesthesia requirement. Accurate, non-invasive tools to
      measure CO could be extremely valuable for patients with CHD that require one-time of
      continuous monitoring of CO, such as during surgery, in intensive care settings, during other
      diagnostic testing, and during different physiologic states such as sleep and exercise. This
      study would begin by comparing cardiac output based on the PhysioFlow monitor to cardiac
      outout by MRI.

      Impedance cardiography is performed by placing electrodes on the thorax and neck to measure
      electrical impedance over time. Cardiac output is derived from these measurements. The
      technique has been studied, validated, and used extensively in adults and has also been shown
      to be valid in children with structurally normal hearts. In contrast, recent studies of
      children with CHD have shown a relatively poor agreement between impedance cardiography and
      both thermodilution technique and velocity encoded phase contrast MRI. The reasons for the
      poor agreement in CHD patients is not yet understood. There are proprietary algorithms in
      each impedance device that use the raw data to calculate and report cardiac output. If the
      physiologic and/or anatomic differences of patients with CHD require changing the algorithm
      within each system to account for such differences, that needs to be done to each system. In
      order to do this, owners of any given device (PhysioFlow, NeuMeDx Inc. in this case) need
      access to the raw data in order to alter the algorithm. This study will involve a concerted
      effort between investigators at RCHSD, UCSD, and NeuMeDx
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Difference in Stroke Volume Between CMR and SMIC</measure>
    <time_frame>2 hours</time_frame>
    <description>Mean difference in stroke volume (SV) between CMR and SMIC measurements in ml</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">21</enrollment>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>CHD patients undergoing cardiac MRI without sedation</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Physioflow</intervention_name>
    <description>impedance cardiography instrument that measures cardiac output non-invasively</description>
    <arm_group_label>CHD patients undergoing cardiac MRI without sedation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Any patient with congenital heart disease that is undergoing cardiac MRI without anesthesia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any form of congenital heart disease

          -  Any age

        Exclusion Criteria:

          -  Subjects with significant clinical skin reactions to electrodes such as excessive pain
             and/or skin inflammation, or significant previous skin reaction

          -  Subjects who are not able to provide consent

          -  Subjects with pacemaker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rady Children's Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2014</study_first_submitted>
  <study_first_submitted_qc>December 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2014</study_first_posted>
  <results_first_submitted>February 28, 2017</results_first_submitted>
  <results_first_submitted_qc>February 28, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 12, 2017</results_first_posted>
  <last_update_submitted>February 28, 2017</last_update_submitted>
  <last_update_submitted_qc>February 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Dr. Christopher Davis</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>cardiac output</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>SMIC and CMR</title>
          <description>Participants with various congenital heart disease diagnoses with both signal-morphology IC (SMIC) measurements and cardiac magnetic resonance (CMR) imaging</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Diagnosis, Age, and Body Size of Subjects</title>
          <description>Overall</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18" lower_limit="7" upper_limit="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
        </measure>
        <measure>
          <title>Body Surface Area</title>
          <units>meters squared</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.67" lower_limit="0.8" upper_limit="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Difference in Stroke Volume Between CMR and SMIC</title>
        <description>Mean difference in stroke volume (SV) between CMR and SMIC measurements in ml</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SMIC and CMR</title>
            <description>Participants with various congenital heart disease diagnoses with both signal-morphology IC (SMIC) measurements and cardiac magnetic resonance (CMR) imaging</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Difference in Stroke Volume Between CMR and SMIC</title>
          <description>Mean difference in stroke volume (SV) between CMR and SMIC measurements in ml</description>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" lower_limit="-3.1" upper_limit="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.47</p_value>
            <method>paired t-test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Intercept for multilinear regression for difference in stroke volume controlling for difference in heart rate and blood pressure</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.255</p_value>
            <method>Regression, Linear</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>6.561</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.528</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.295</ci_lower_limit>
            <ci_upper_limit>18.417</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Heart rate delta for multilinear regression for difference in stroke volume controlling for difference in heart rate and blood pressure</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.250</p_value>
            <method>Regression, Linear</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.500</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.417</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.395</ci_lower_limit>
            <ci_upper_limit>1.395</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Diastolic BP delta for multilinear regression for difference in stroke volume controlling for difference in heart rate and blood pressure</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.183</p_value>
            <method>Regression, Linear</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.427</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.305</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.081</ci_lower_limit>
            <ci_upper_limit>0.227</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Systolic BP delta for multilinear regression for difference in stroke volume controlling for difference in heart rate and blood pressure</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.238</p_value>
            <method>Regression, Linear</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.557</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.452</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.411</ci_lower_limit>
            <ci_upper_limit>1.526</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>CHD Patients Undergoing Cardiac MRI Without Sedation</title>
          <description>Physioflow: impedance cardiography instrument that measures cardiac output non-invasively</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Christopher Davis</name_or_title>
      <organization>UCSD</organization>
      <phone>8589665855 ext 5668</phone>
      <email>cdavis@rchsd.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

